eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | carcinoid syndrome |
| Comorbidity | C0206754|neuroendocrine tumour |
| Sentences | 2 |
| PubMedID- 22119496 | Interpretation: everolimus plus octreotide lar, compared with placebo plus octreotide lar, improved progression-free survival in patients with advanced neuroendocrine tumours associated with carcinoid syndrome. |
| PubMedID- 24463166 | [treatment of metastatic midgut neuroendocrine tumour associated with carcinoid syndrome]. |
Page: 1